Abivax S.A.

Related records

Trials (23)

• A Safety, Pharmacokinetics, and Pharmacodynamics Study of ABX464 in HIV-1 Seronegative and Seropositive Adults
• ABTECT - Maintenance
• ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1
• ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2
• ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma
• ABX464 First in Man Study
• ABX464 in Fully Controlled HIV Infected Patients Treated With Boosted Protease Inhibitor Treatment
• ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis
• ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19
• Clinical Efficacy of ABX203 Therapeutic Vaccine in HBeAg Negative Patients With Chronic Hepatitis B
• Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis
• Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
• Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative Colitis
• Evaluation of the Potential CYP1A2-mediated Drug Drug Interaction Safety, and Tolerability of ABX464
• Food Effect on Pharmacokinetic Parameters of ABX464
• Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis
• Phase 2b/3 Study of ABX464 in Moderate to Severe Active Crohn's Disease Patients
• Safety and Pharmacokinetics Study in Healthy Japanese Volunteers
• Safety, PK and PD Study of ABX464 in Untreated HIV Patients
• Study Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative Colitis